PepGen (PEPG) Cash & Equivalents (2021 - 2026)

PepGen (PEPG) has 6 years of Cash & Equivalents data on file, last reported at $42.2 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 3.4% year-over-year to $42.2 million; the trailing twelve-month figure through Mar 2026 stood at $42.2 million (down 3.4% YoY), and the FY2025 full-year result was $60.5 million, up 22.45% from the prior year.
• Cash & Equivalents retreated to $42.2 million in Q1 2026, from $60.5 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $218.8 million in Q2 2022 to a low of $35.1 million in Q2 2025.
• A 5-year average of $109.0 million and a median of $118.9 million in 2022 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents soared 1682.72% in 2022 and sank 67.4% in 2025, its largest moves.
• Tracing PEPG's Cash & Equivalents over 5 years: stood at $181.8 million in 2022, then sank by 55.56% to $80.8 million in 2023, then tumbled by 38.82% to $49.4 million in 2024, then rose by 22.45% to $60.5 million in 2025, then plunged by 30.35% to $42.2 million in 2026.
• Business Quant data shows PEPG's Cash & Equivalents at $42.2 million in Q1 2026, $60.5 million in Q4 2025, and $142.8 million in Q3 2025.